Journal of Nuclear Medicine August 2026, jnumed.125.271853; DOI: https://doi.org/10.2967/jnumed.125.271853 ...
Journal of Nuclear Medicine October 2019, jnumed.119.233122; DOI: https://doi.org/10.2967/jnumed.119.233122 ...
Journal of Nuclear Medicine July 2026, jnumed.126.272545; DOI: https://doi.org/10.2967/jnumed.126.272545 ...
Developing novel radiopharmaceuticals for cancer theranostics has recently attracted extensive interest. Bifunctional chelators are key components of many radiometal-based radiopharmaceuticals. For ...
Journal of Nuclear Medicine June 2026, jnumed.125.271856; DOI: https://doi.org/10.2967/jnumed.125.271856 ...
Journal of Nuclear Medicine March 2026, jnumed.125.271976; DOI: https://doi.org/10.2967/jnumed.125.271976 ...
Journal of Nuclear Medicine March 2026, jnumed.125.271601; DOI: https://doi.org/10.2967/jnumed.125.271601 ...
Journal of Nuclear Medicine March 2026, jnumed.125.271031; DOI: https://doi.org/10.2967/jnumed.125.271031 ...
Journal of Nuclear Medicine December 2025, jnumed.125.270175; DOI: https://doi.org/10.2967/jnumed.125.270175 ...
Journal of Nuclear Medicine September 2025, jnumed.124.268809; DOI: https://doi.org/10.2967/jnumed.124.268809 ...
Solitary fibrous tumor (SFT) is a rare soft-tissue sarcoma with limited treatment options, especially in advanced or metastatic cases. Fibroblast activation protein α (FAPα) is overexpressed in ...